A detailed history of Sbi Securities Co., Ltd. transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 200 shares of CLGN stock, worth $750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$750
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$3.25 - $4.92 $650 - $984
200 New
200 $720,000

Others Institutions Holding CLGN

About CollPlant Biotechnologies Ltd


  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $41.6M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.